FUSEMACHINES INC (FUSE) Fundamental Analysis & Valuation

NASDAQ:FUSE • US36118R1032

Current stock price

1.83 USD
+0.98 (+115.29%)
At close:
1.742 USD
-0.09 (-4.81%)
After Hours:

This FUSE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FUSE Profitability Analysis

1.1 Basic Checks

  • FUSE had negative earnings in the past year.
FUSE Yearly Net Income VS EBIT VS OCF VS FCFFUSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 2M 4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -181.10%, FUSE is doing worse than 90.91% of the companies in the same industry.
Industry RankSector Rank
ROA -181.1%
ROE N/A
ROIC N/A
ROA(3y)3.66%
ROA(5y)N/A
ROE(3y)4.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FUSE Yearly ROA, ROE, ROICFUSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FUSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FUSE Yearly Profit, Operating, Gross MarginsFUSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. FUSE Health Analysis

2.1 Basic Checks

  • FUSE has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for FUSE is higher compared to a year ago.
FUSE Yearly Shares OutstandingFUSE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
FUSE Yearly Total Debt VS Total AssetsFUSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • FUSE has an Altman-Z score of -7.05. This is a bad value and indicates that FUSE is not financially healthy and even has some risk of bankruptcy.
  • FUSE has a Altman-Z score of -7.05. This is amonst the worse of the industry: FUSE underperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.05
ROIC/WACCN/A
WACCN/A
FUSE Yearly LT Debt VS Equity VS FCFFUSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • FUSE has a Current Ratio of 0.28. This is a bad value and indicates that FUSE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of FUSE (0.28) is worse than 92.05% of its industry peers.
  • FUSE has a Quick Ratio of 0.28. This is a bad value and indicates that FUSE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FUSE has a Quick ratio of 0.28. This is amonst the worse of the industry: FUSE underperforms 92.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
FUSE Yearly Current Assets VS Current LiabilitesFUSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. FUSE Growth Analysis

3.1 Past

  • The earnings per share for FUSE have decreased strongly by -92.10% in the last year.
EPS 1Y (TTM)-92.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. FUSE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FUSE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FUSE Price Earnings VS Forward Price EarningsFUSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FUSE Per share dataFUSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FUSE Dividend Analysis

5.1 Amount

  • No dividends for FUSE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FUSE Fundamentals: All Metrics, Ratios and Statistics

FUSEMACHINES INC

NASDAQ:FUSE (4/10/2026, 8:26:34 PM)

After market: 1.742 -0.09 (-4.81%)

1.83

+0.98 (+115.29%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-27
Earnings (Next)N/A
Inst Owners24.84%
Inst Owner Change0%
Ins Owners32.64%
Ins Owner Change92.86%
Market Cap52.96M
Revenue(TTM)N/A
Net Income(TTM)-22.37M
Analysts0
Price TargetN/A
Short Float %2.84%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.88
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS-1.09
TBVpS-1.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -181.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.66%
ROA(5y)N/A
ROE(3y)4.97%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z -7.05
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.43%
OCF growth 3YN/A
OCF growth 5YN/A

FUSEMACHINES INC / FUSE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FUSEMACHINES INC (FUSE) stock?

ChartMill assigns a fundamental rating of 0 / 10 to FUSE.


What is the valuation status of FUSEMACHINES INC (FUSE) stock?

ChartMill assigns a valuation rating of 0 / 10 to FUSEMACHINES INC (FUSE). This can be considered as Overvalued.


How profitable is FUSEMACHINES INC (FUSE) stock?

FUSEMACHINES INC (FUSE) has a profitability rating of 0 / 10.